Cargando…
Suppression of established hepatocarcinoma in adjuvant only immunotherapy: alum triggers anti-tumor CD8(+) T cell response
Dendritic cell-based immunotherapy is a new weapon in our battle against malignancies in human. Recent trials in human and research work in model animals have shown various degrees of success, suggesting its great potential for clinical use. While protocols vary, a common scheme in this category of...
Autores principales: | Wang, Bo, Wang, Xuanyi, Wen, Yumei, Fu, Jing, Wang, Hongyang, Ma, Zhangmei, Shi, Yan, Wang, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673419/ https://www.ncbi.nlm.nih.gov/pubmed/26647964 http://dx.doi.org/10.1038/srep17695 |
Ejemplares similares
-
Alum Pickering Emulsion as Effective Adjuvant to Improve Malaria Vaccine Efficacy
por: Chen, Qiuting, et al.
Publicado: (2021) -
Alum: an old dog with new tricks
por: Wen, Yumei, et al.
Publicado: (2016) -
Engineered immunogen binding to alum adjuvant enhances humoral immunity
por: Moyer, Tyson J., et al.
Publicado: (2020) -
Advancements in Vaccine Adjuvants: The Journey from Alum to Nano Formulations
por: Moni, Sivakumar S., et al.
Publicado: (2023) -
Alum Addition Triggers Hypoxia in an Engineered Pit Lake
por: Jessen, Gerdhard L., et al.
Publicado: (2022)